Next Article in Journal / Special Issue
Molecular Insights into Poly(ADP-ribose) Recognition and Processing
Previous Article in Journal / Special Issue
Decorin Content and Near Infrared Spectroscopy Analysis of Dried Collagenous Biomaterial Samples
 
 
Review

Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy

Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden
*
Author to whom correspondence should be addressed.
Biomolecules 2012, 2(4), 635-649; https://doi.org/10.3390/biom2040635
Received: 12 October 2012 / Revised: 29 November 2012 / Accepted: 9 December 2012 / Published: 14 December 2012
(This article belongs to the Special Issue DNA Damage Response)
Treatments with Poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors have offered patients carrying cancers with mutated BRCA1 or BRCA2 genes a new and in many cases effective option for disease control. There is potentially a large patient population that may also benefit from PARP inhibitor treatment, either in monotherapy or in combination with chemotherapy. Here, we describe the multifaceted role of PARP inhibitors and discuss which treatment options could potentially be useful to gain disease control without potentiating side effects. View Full-Text
Keywords: DNA repair; poly(ADP-ribose) polymerase; synthetic lethality; cancer DNA repair; poly(ADP-ribose) polymerase; synthetic lethality; cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Ström, C.E.; Helleday, T. Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy. Biomolecules 2012, 2, 635-649. https://doi.org/10.3390/biom2040635

AMA Style

Ström CE, Helleday T. Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy. Biomolecules. 2012; 2(4):635-649. https://doi.org/10.3390/biom2040635

Chicago/Turabian Style

Ström, Cecilia E., and Thomas Helleday. 2012. "Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy" Biomolecules 2, no. 4: 635-649. https://doi.org/10.3390/biom2040635

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop